If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBegbies Regulatory News (BEG)

  • There is currently no data for BEG

Directorate Change

1 Feb 2023 07:00

RNS Number : 4840O
Begbies Traynor Group PLC
01 February 2023
 

1 February 2023

 

Begbies Traynor Group plc

 

Directorate change

 

Appointment of new independent non-executive director

 

Begbies Traynor Group plc (the 'company' or the 'group'), the business recovery, financial advisory and property services consultancy, announces the appointment of Mandy Donald to the board as an additional independent non-executive director with immediate effect; she will also join the board's audit committee.

 

Mandy is a chartered accountant and experienced non-executive director. She joined EY in 1992, qualified as a chartered accountant and spent 10 years working in professional roles in the firm. In 2002 she was appointed as EY's UK director of finance and operations and from 2007-2012 was the global director of finance and operations for EY's transaction advisory services and EY assurance services.

 

Since 2012, Mandy has held a number of non-executive director positions in the financial and professional services sectors including at Punter Southall, Liontrust Asset Management plc, JP Morgan Investment Trust plc and Gowling WLG LLP, as well as in the not for profit sector at the Institute of Cancer Research; these roles included acting as chair of several audit committee and risk committees.

 

Commenting on Mandy's appointment, Ric Traynor, Executive Chairman said:

 

"I am delighted that Mandy is joining Begbies Traynor Group's board; she brings valuable and relevant experience from her executive and non-executive roles and will complement and broaden the board's existing skills and expertise. We look forward to working with her."

 

Regulatory disclosures

 

Full name

Mandy Donald

Age

50

Shareholding in the Company

No shares held

Current directorships and partnerships

JPMorgan US Smaller Companies Investment Trust plc

Liontrust Asset Management plc

Punter Southall Group Limited

Institute of Cancer Research: Royal Cancer Hospital

Directorships and partnerships held within the past five years

Liontrust Multi-Asset Limited

 

 

 

Save as set out in this announcement, there are no further disclosures required under Rule 17 Schedule 2 (g) of the AIM Rules.

- ENDS -

 

Enquiries please contact:

Begbies Traynor Group PLC 0161 837 1700

Ric Traynor - Executive Chairman

Nick Taylor - Group Finance Director

 

Canaccord Genuity Limited 020 7523 8000

(Nominated Adviser and Joint Broker)

Emma Gabriel / Patrick Dolaghan

 

Shore Capital 020 7408 4090

(Joint Broker)

Malachy McEntyre / Mark Percy / Anita Ghanekar / James Thomas

 

MHP Communications 020 3128 8567

Reg Hoare / Katie Hunt / Pauline Guenot begbies@mhpc.com

Further information on Begbies Traynor Group can be accessed via the Group's website at www.begbies-traynorgroup.com/investor-relations

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASDSFWFEDSEIF
Date   Source Headline
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20241:28 pmRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 202412:22 pmRNSBlock Listing Six Monthly Return
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSLaunch of Share Buyback Programme
17th Oct 202410:08 amRNSDirector/PDMR Shareholding
16th Oct 20244:45 pmRNSExercise of Options
30th Sep 202411:53 amRNSTotal Voting Rights
17th Sep 202411:01 amRNSResult of AGM
17th Sep 20247:00 amRNSAGM Statement
30th Aug 20244:15 pmRNSTotal Voting Rights
14th Aug 20246:00 pmRNSNotice of Annual General Meeting
12th Jul 20243:52 pmRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSFinal Results
5th Jul 202412:23 pmRNSTotal Voting Rights
3rd Jun 202410:18 amRNSTotal Voting Rights
21st May 20247:00 amRNSYear end trading update
2nd May 202412:38 pmRNSEBT Share Purchase
30th Apr 20241:44 pmRNSTotal Voting Rights
29th Apr 20243:41 pmRNSEBT Share Purchase
26th Apr 20242:54 pmRNSBlock Listing Six Monthly Return
26th Apr 20247:00 amRNSLatest Red Flag Alert Report for Q1 2024
22nd Apr 20241:39 pmRNSEBT Share Purchase
15th Apr 20247:06 amRNSEBT Share Purchase
11th Apr 20241:49 pmRNSEBT Share Purchase
8th Apr 20247:00 amRNSEBT Share Purchase
2nd Apr 20244:13 pmRNSEBT Share Purchase
25th Mar 20249:13 amRNSEBT Share Purchase
18th Mar 20249:23 amRNSEBT Share Purchase
11th Mar 20249:34 amRNSEBT Share Purchase
4th Mar 20247:00 amRNSTotal Voting Rights
4th Mar 20247:00 amRNSEBT Share Purchase
29th Feb 202412:22 pmRNSGrant of Share Options and PDMR
26th Feb 20249:21 amRNSEBT Share Purchase
26th Feb 20247:00 amRNS3rd Quarter Trading Update and New Debt Facility
19th Feb 202410:59 amRNSEBT Share Purchase
5th Feb 20249:43 amRNSEBT Share Purchase
1st Feb 20246:15 pmRNSTotal Voting Rights
29th Jan 20249:53 amRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.